Pharma Focus Europe

Press Releases

Our team at believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.

Allarity Therapeutics and FivepHusion Announce Collaboration to Support Clinical Development of Deflexifol™ with DRP® Companion Diagnostics

Monday, July 31, 2023

Allarity Therapeutics Inc Nasdaq ALLR Allarity a clinicalstage pharmaceutical company developing novel oncology therapeutics together with drugspecific DRP companion diagnostics for personalized cancer care

Ionis expands eplontersen agreement with AstraZeneca to include exclusive rights in Latin America

Saturday, July 29, 2023

Ionis Pharmaceuticals Inc Nasdaq IONS today announced it has expanded its existing collaboration with AstraZeneca to include exclusive rights for AstraZeneca to commercialize eplontersen in Latin America

Norgine amplía el compromiso científico con Veeva Link Key People

Friday, July 28, 2023

Veeva Systems NYSE VEEV ha anunciado hoy que Norgine BV Norgine una compaa farmacutica especializada lder en Europa est utilizando la inteligencia de clientes en tiempo real de Veeva Link Key People para liderar la planificacin de lanzamiento efectiv...

Ayala Pharmaceuticals and Biosight Enter into Definitive Merger Agreement

Friday, July 28, 2023

Ayala Pharmaceuticals Inc OTCQX ADXS a publiclytraded clinicalstage oncology company and Biosight Ltd a privatelyheld pharmaceutical company developing innovative therapeutics for hematological malignancies and disorders today announced they have ent...

AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets

Thursday, July 27, 2023

AbbVie NYSEABBV and Calibr today announced an expanded strategic collaboration to advance several innovative preclinical and earlystage clinical assets across AbbVies core therapeutic growth areas including immunology oncology neuroscience and other...

Societal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities to Address Expanding Psychedelic Drug Development Market

Thursday, July 27, 2023

Societal CDMO Inc Societal CDMO Nasdaq SCTL a contract development and manufacturing organization CDMO dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development today announced the expan...

IntelGenx Provides Update on Research Collaboration Evaluating Montelukast VersaFilm® for the Treatment of Parkinson’s Disease

Wednesday, July 26, 2023

IntelGenx Corp TSXIGXOTCQBIGXT the Company or IntelGenx today announced the execution of a Research Grant Agreement with Karolinska University Hospital and that the manufacturing of both active and placebo films are underway in preparation for a plan...

Curium Announces License and Development Agreement With Lantheus for AI-Based PSMA PET Software in Europe

Wednesday, July 26, 2023

Curium a world leader in nuclear medicine announced today a License and Development agreement with EXINI Diagnostics AB a Lantheus company EXINI to customize EXINIs artificial intelligence AI platform for use in Europe The agreement builds on the exi...

SQZ Biotechnologies Provides Update on Collaboration with Roche

Wednesday, July 26, 2023

SQZ Biotechnologies Company OTC SQZB the Company or SQZ today announced that Roche has determined that it will not exercise its option for HPV positive solid tumors under the SQZAPCHPV program SQZ Biotechnologies will regain full clinical developmen...

Biovian announces over €50 million investment in manufacturing facility in Turku, Finland

Wednesday, July 26, 2023

Biovian a leading contract development and manufacturing organization CDMO specializing in biopharmaceuticals has announced a major investment of over million to expand its manufacturing facility in Turku Finland